Minerva Neurosciences Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Minerva Neurosciences, Inc. (NERV) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Current Assets
Cash and Cash Equivalents21.3640.9136.0960.7625.3645.9588.00
Cash & Short-Term Investments21.3640.9136.0960.7625.3645.9588.00
Accounts Receivable0.000.003.120.000.000.000.00
Inventory0.000.000.000.000.000.000.00
Other Current Assets0.810.990.851.351.980.000.00
Total Current Assets22.2742.0040.1662.2027.4447.1490.02
Non-Current Assets
Property, Plant & Equipment (Net)0.010.010.020.000.100.280.03
Goodwill14.8714.8714.8714.8714.870.000.00
Intangible Assets0.000.020.040.050.000.000.00
Other Non-Current Assets0.000.003.120.000.010.010.01
Total Non-Current Assets14.8714.9018.0514.9230.1930.3649.12
Total Assets37.1456.9055.0977.1257.6377.50139.14
Current Liabilities
Accounts Payable1.611.810.971.853.056.463.61
Accrued Liabilities0.871.540.410.972.050.000.00
Other Current Liabilities1.2382.020.000.000.000.000.00
Total Current Liabilities2.843.341.382.823.166.633.61
Non-Current Liabilities
Long-Term Debt60.0082.0273.7366.330.000.110.00
Deferred Tax Liabilities0.000.000.000.001.800.000.00
Other Non-Current Liabilities60.0082.0273.7366.330.000.000.03
Total Non-Current Liabilities60.0082.0273.7366.331.8043.0945.26
Total Liabilities62.8485.3675.1169.154.9649.7248.87
Stockholders' Equity
Common Stock0.000.000.000.000.000.000.00
Retained Earnings-395.38-396.82-366.81-334.70-284.80-286.74-214.55
Additional Paid-in Capital369.68368.36346.79342.68337.45314.51304.81
Shares Outstanding6.996.995.345.340.000.000.00
Total Stockholders' Equity-25.69-28.46-20.027.9852.6627.7890.26
Total Liabilities & Equity37.1456.9055.0977.1257.6377.50139.14